Showing results (2741-2750 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|November 16, 2020
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)Simon Fietz, Romina Zarbl, Dennis Niebel, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2020
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapyGilli Galore-Haskel, Eyal Greenberg, Inbal Yahav, et al.
Cancer Immunology, Immunotherapy : CII|November 3, 2020
The role of dendritic cells for therapy of B-cell lymphoma with immune checkpoint inhibitorsAnne Scheuerpflug, Fatima Ahmetlić, Vera Bauer, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2022
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)Renaud Descourt, Laurent Greillier, Maurice Perol, et al.
Cancer Immunology, Immunotherapy : CII|January 8, 2023
Predictive value of p53 and AXL immunostaining for the efficacy of immune checkpoint inhibitor-based therapy after osimertinib treatment in patients with epidermal growth factor-mutant non-small cell lung cancerKenji Morimoto, Tadaaki Yamada, Ryo Sawada, et al.
Cancer Immunology, Immunotherapy : CII|January 9, 2023
A nanotherapeutic system for gastric cancer suppression by synergistic chemotherapy and immunotherapy based on iPSCs and DCs exosomesYezhou Li, Leilei Tian, Tiancheng Zhao, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2023
Comprehensive analysis of immune subtypes reveals the prognostic value of cytotoxicity and FAP+ fibroblasts in stomach adenocarcinomaXin Wang, Sun Hui, Cong Tan, et al.
Cancer Immunology, Immunotherapy : CII|January 23, 2023
Multivalent adaptor proteins specifically target NK cells carrying a universal chimeric antigen receptor to ErbB2 (HER2)-expressing cancersJordi Pfeifer Serrahima, Congcong Zhang, Pranav Oberoi, et al.
Cancer Immunology, Immunotherapy : CII|January 23, 2023
Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumabAnna Siemiątkowska, Maciej Bryl, Katarzyna Kosicka-Noworzyń, et al.
Cancer Immunology, Immunotherapy : CII|January 14, 2023
Association between pre-treatment chest imaging and pulmonary function abnormalities and immune checkpoint inhibitor pneumonitisAlex Wong, Maria Riley, Songzhu Zhao, et al.
Pageof 652